首页> 外国专利> A MIXTURE OF OXALACETATE, ALPHA-KETOGLUTARATE, TARTARIC ACID AND SALTS OF CALCIUM AND SODIUM LACTATE, FOR TREATING PATIENTS WITH CHRONIC RENAL INSUFFICIENCY.

A MIXTURE OF OXALACETATE, ALPHA-KETOGLUTARATE, TARTARIC ACID AND SALTS OF CALCIUM AND SODIUM LACTATE, FOR TREATING PATIENTS WITH CHRONIC RENAL INSUFFICIENCY.

机译:草酸盐,α-酮戊二酸,酒石酸和钙和乳酸钠的混合物,用于治疗慢性肾功能不全的患者。

摘要

The present invention relates to a mixture of carboxylic acids: oxaloacetate, alpha-ketoglutarate, tartaric acid and calcium and/or sodium salts of lactic acid combined with sodium bicarbonate and calcium carbonate, for the oral treatment of patients with chronic renal failure (stages IV and V of KDOQI), hyperamonemia or human conditions that occur with a negative nitrogen balance. Said mixture is preferably administered orally but also intravenously, thus causing to decrease the serum and ammonium values, and promoting the biosynthesis of non-essential amino acids. Also, it improves the nutritional status and raises the serum albumin levels. This treatment prevents and preserves the renal function, delaying the need for renal replacement treatment (peritoneal dialysis, hemodialysis, renal transplantation).
机译:本发明涉及羧酸的混合物:草酰乙酸,α-酮戊二酸,酒石酸和乳酸的钙和/或钠盐与碳酸氢钠和碳酸钙的组合,用于口服治疗慢性肾衰竭的患者(IV期)和VDO(KDOQI),高氨血症或人体状况,且氮平衡处于负数。所述混合物优选经口但也经静脉内施用,从而导致降低血清和铵值,并促进非必需氨基酸的生物合成。而且,它改善了营养状况并提高了血清白蛋白水平。这种治疗可预防和保留肾脏功能,从而延迟了肾脏替代治疗(腹膜透析,血液透析,肾移植)的需要。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号